Max Healthcare Institute Limited reported robust financial results for the quarter and year ended March 31, 2026. The company achieved a consolidated annual revenue of ₹8,53,607 lakh and a net profit of ₹1,44,241 lakh. Alongside financial growth, the Board approved significant expansion plans, including the construction of a new 712-bed hospital in Lucknow, and recommended a final dividend of ₹2 per equity share for shareholders.
Annual Financial Highlights
For the financial year ended March 31, 2026, Max Healthcare delivered impressive growth. Consolidated revenue from operations climbed to ₹8,37,345 lakh, contributing to a total income of ₹8,53,607 lakh for the year. Net profit for the period reached ₹1,44,241 lakh, reflecting a strong operational performance. For the final quarter (Q4) ending March 31, 2026, the company recorded a revenue of ₹2,14,289 lakh and a quarterly net profit of ₹34,222 lakh.
Strategic Expansion and Infrastructure
The company is committed to scaling its network to meet rising demand. The Board has approved the development of Phase-I of a new Max Super Specialty Hospital in Lucknow. This project will be situated on a 5-acre land parcel and is designed to accommodate approximately 712 census beds. This expansion is essential, as existing network facilities have been operating at high capacity utilization, exceeding 75% in Q4.
Dividend and Governance Updates
Reflecting the company’s healthy profitability, the Board has recommended a final dividend of ₹2 per equity share (representing 20% of the face value of ₹10) for the financial year 2025-26. This payout remains subject to approval at the upcoming Annual General Meeting.
In addition to financial milestones, the Board approved the re-appointment of Mr. Anil Kumar Bhatnagar as a Non-Executive and Non-Independent Director for a three-year term, effective October 1, 2026. Furthermore, the company has initiated the process to shift its registered office from the state of Maharashtra to Haryana.
Source: BSE
